Since Help With is a general information site, I have decided not to flood our pages with too many specific abstracts or study results from here at ASH unless they are truly significant.  Here is a general leukemia related release which summarizes the impact from some of today’s research study data:

Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias
December 4, 2010
(ORLANDO) – Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML), and how a new gene target functions for several myeloid malignancies.

“Each year, we continue to make significant strides in better understanding the underlying role certain genes play in the development of various forms of leukemia,” said moderator of the press conference Peter Emanuel, MD, Director of the Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock. “These studies underscore the advances we are making to develop a new generation of treatment options that will improve overall outcomes for our patients.”

Feel good and keep smiling!  Pat

Leave a Reply